• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于预测重症监护病房侵袭性肺曲霉病的新型诊断评分模型。

A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit.

作者信息

Rozaliyani Anna, Sedono Rudyanto, Jusuf Anwar, Rumende Cleopas M, Aniwidyaningsih Wahju, Burhan Erlina, Prasenohadi Prasenohadi, Handayani Diah, Yunihastuti Evy, Siagian Forman E, Jayusman Achmad M, Rusli Adria, Sungkar Saleha, Prihartono Joedo, Hagen Ferry, Meis Jacques F, Wahyuningsih Retno

机构信息

Department of Parasitology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia. E-mail.

出版信息

Saudi Med J. 2019 Feb;40(2):140-146. doi: 10.15537/smj.2019.2.22940.

DOI:10.15537/smj.2019.2.22940
PMID:30723858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6402463/
Abstract

OBJECTIVES

To improve the quality of invasive pulmonary aspergillosis (IPA) management for intensive care unit (ICU) patients using a practical diagnostic scoring model.

METHODS

This nested case-control study aimed to determine the incidence of IPA in 405 ICU patients, between July 2012 and June 2014, at 6 hospitals in Jakarta, Indonesia. Phenotypic identifications and galactomannan (GM) tests of sera and lung excreta were performed in mycology laboratory, Parasitology Department, Faculty of Medicine, Universitas Indonesia in Jakarta, Indonesia.

RESULTS

The incidence of IPA in the ICUs was 7.7% (31 of 405 patients). A scoring model used for IPA diagnosis showed 4 variables as the most potential risk factors: lung excreta GM index (score 2), solid organ malignancy (score 2), pulmonary tuberculosis (score 2), and systemic corticosteroids (score 1). Patients were included in a high-risk group if their score was greater than 2, and in a low-risk group if their score was less than 2.

CONCLUSION

This study provides a novel diagnosis scoring model to predict IPA in ICU patients. Using this model, a more rapid diagnosis and treatment of IPA may be possible. The application of the diagnosis scoring should be preceded by specified pre-requisites.

摘要

目的

使用一种实用的诊断评分模型提高重症监护病房(ICU)患者侵袭性肺曲霉病(IPA)的管理质量。

方法

这项巢式病例对照研究旨在确定2012年7月至2014年6月期间印度尼西亚雅加达6家医院405例ICU患者中IPA的发病率。在印度尼西亚雅加达印度尼西亚大学医学院寄生虫学系的真菌学实验室对血清和肺排泄物进行表型鉴定和半乳甘露聚糖(GM)检测。

结果

ICU中IPA的发病率为7.7%(405例患者中的31例)。用于IPA诊断的评分模型显示4个变量为最潜在的危险因素:肺排泄物GM指数(评分2)、实体器官恶性肿瘤(评分2)、肺结核(评分2)和全身用皮质类固醇(评分1)。评分大于2的患者被纳入高危组,评分小于2的患者被纳入低危组。

结论

本研究提供了一种预测ICU患者IPA的新型诊断评分模型。使用该模型,可能实现对IPA更快速的诊断和治疗。诊断评分的应用应以特定的先决条件为前提。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63d/6402463/89722686a997/SaudiMedJ-40-140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63d/6402463/89722686a997/SaudiMedJ-40-140-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d63d/6402463/89722686a997/SaudiMedJ-40-140-g003.jpg

相似文献

1
A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit.一种用于预测重症监护病房侵袭性肺曲霉病的新型诊断评分模型。
Saudi Med J. 2019 Feb;40(2):140-146. doi: 10.15537/smj.2019.2.22940.
2
[Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].[非中性粒细胞减少的重症监护病房患者侵袭性肺曲霉病危险因素评估及支气管肺泡灌洗样本中半乳甘露聚糖和PCR方法诊断价值的检测]
Mikrobiyol Bul. 2015 Oct;49(4):565-75. doi: 10.5578/mb.9906.
3
Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients.在免疫抑制的机械通气重症患者中,比较血清和支气管肺泡灌洗液中1,3-β-D-葡聚糖与半乳甘露聚糖用于检测曲霉菌种的情况。
J Crit Care. 2016 Dec;36:259-264. doi: 10.1016/j.jcrc.2016.06.026. Epub 2016 Jul 9.
4
COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave.COVID-19 相关的肺曲霉病、菌血症和肺囊虫病在重症监护病房:法国第一波大流行期间的回顾性多中心观察队列研究。
Microbiol Spectr. 2021 Oct 31;9(2):e0113821. doi: 10.1128/Spectrum.01138-21. Epub 2021 Oct 20.
5
Risk factors and the value of microbiological examinations of COVID-19 associated pulmonary aspergillosis in critically ill patients in intensive care unit: the appropriate microbiological examinations are crucial for the timely diagnosis of CAPA.危重症患者 COVID-19 相关侵袭性肺曲霉病的危险因素及微生物学检查价值:及时诊断 CAPA 时,合适的微生物学检查至关重要。
Front Cell Infect Microbiol. 2023 Nov 21;13:1287496. doi: 10.3389/fcimb.2023.1287496. eCollection 2023.
6
Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies.BAL 中半乳甘露聚糖抗原检测对血液恶性肿瘤患者侵袭性肺曲霉病的诊断价值。
Chest. 2010 Feb;137(2):410-5. doi: 10.1378/chest.09-0701. Epub 2009 Oct 3.
7
Role of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective study.半乳甘露聚糖检测在慢性阻塞性肺疾病重症患者支气管肺泡灌洗样本中对侵袭性肺曲霉病诊断的作用:一项前瞻性研究
Crit Care. 2012 Jul 27;16(4):R138. doi: 10.1186/cc11443.
8
Invasive pulmonary aspergillosis in acute exacerbation of chronic obstructive pulmonary disease and the diagnostic value of combined serological tests.慢性阻塞性肺疾病急性加重期侵袭性肺曲霉病及血清学联合检测的诊断价值
Ann Saudi Med. 2010 May-Jun;30(3):193-7. doi: 10.4103/0256-4947.62828.
9
Diagnostic yield of a bronchoalveolar lavage fluid galactomannan assay in patients with negative serum galactomannan results suspected to have invasive pulmonary aspergillosis.疑似侵袭性肺曲霉病而血清半乳甘露聚糖检测结果阴性患者支气管肺泡灌洗液半乳甘露聚糖检测的诊断效能。
Mycoses. 2021 Sep;64(9):1124-1131. doi: 10.1111/myc.13269. Epub 2021 May 24.
10
The role of pentraxin3 in plasma and bronchoalveolar lavage fluid in COPD patients with invasive pulmonary aspergillosis.血清五聚素 3 在合并侵袭性肺曲霉病的 COPD 患者中的血浆和支气管肺泡灌洗液中的作用。
BMC Pulm Med. 2021 Dec 16;21(1):414. doi: 10.1186/s12890-021-01793-z.

引用本文的文献

1
Diagnostic Utility of Galactomannan Enzyme Immunoassay in Invasive Aspergillosis in Pediatric patients with Hematological Malignancy.半乳甘露聚糖酶联免疫吸附试验在血液恶性肿瘤患儿侵袭性曲霉菌病中的诊断价值。
Mycopathologia. 2023 Dec;188(6):1055-1063. doi: 10.1007/s11046-023-00798-y. Epub 2023 Oct 9.
2
Analysis of Fungal and Bacterial Co-Infections in Mortality Cases among Hospitalized Patients with COVID-19 in Taipei, Taiwan.台湾台北地区新冠肺炎住院死亡病例中的真菌与细菌合并感染分析
J Fungi (Basel). 2022 Jan 17;8(1):91. doi: 10.3390/jof8010091.
3
Epidemiological Correlation of Pulmonary Infections with Ambient Pollutions and Influenza A (H1N1) in Southern Taiwan.

本文引用的文献

1
Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings.资源有限环境下慢性肺曲霉病的病例定义。
Emerg Infect Dis. 2018 Aug;24(8). doi: 10.3201/eid2408.171312.
2
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.曲霉病的诊断和治疗:2017 年 ESCMID-ECMM-ERS 指南执行摘要。
Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.
3
Erratum: Epidemiology and clinical characteristics of invasive mould infections: A multicenter, retrospective analysis in five Asian countries.
台湾南部肺部感染与环境污染及甲型流感(H1N1)的流行病学关联
J Fungi (Basel). 2021 Mar 19;7(3):227. doi: 10.3390/jof7030227.
4
Diagnostic Accuracy of Bronchoalveolar Lavage Fluid Galactomannan for Invasive Aspergillosis.支气管肺泡灌洗液半乳甘露聚糖检测对侵袭性曲霉病的诊断准确性。
Biomed Res Int. 2020 Nov 30;2020:5434589. doi: 10.1155/2020/5434589. eCollection 2020.
勘误:侵袭性霉菌感染的流行病学与临床特征:一项在五个亚洲国家开展的多中心回顾性分析。
Med Mycol. 2018 Apr 1;56(3):387. doi: 10.1093/mmy/myx055.
4
Invasive Pulmonary Fungal Infections in Cystic Fibrosis.囊性纤维化患者的肺部侵袭性真菌感染。
Mycopathologia. 2018 Feb;183(1):33-43. doi: 10.1007/s11046-017-0199-4. Epub 2017 Sep 1.
5
Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013.2000 - 2013年美国侵袭性曲霉病和毛霉病相关住院情况的趋势
Open Forum Infect Dis. 2017 Jan 13;4(1):ofw268. doi: 10.1093/ofid/ofw268. eCollection 2017 Winter.
6
Diagnostic Value of Galactomannan Antigen Test in Serum and Bronchoalveolar Lavage Fluid Samples from Patients with Nonneutropenic Invasive Pulmonary Aspergillosis.半乳甘露聚糖抗原检测在非中性粒细胞减少的侵袭性肺曲霉病患者血清和支气管肺泡灌洗样本中的诊断价值
J Clin Microbiol. 2017 Jul;55(7):2153-2161. doi: 10.1128/JCM.00345-17. Epub 2017 Apr 26.
7
Influenza-Associated Aspergillosis in Critically Ill Patients.重症患者中的流感相关性曲霉病
Am J Respir Crit Care Med. 2017 Aug 15;196(4):524-527. doi: 10.1164/rccm.201612-2540LE. Epub 2017 Apr 7.
8
Invasive mould infections in the ICU setting: complexities and solutions.重症监护病房环境中的侵袭性霉菌感染:复杂性与解决方案
J Antimicrob Chemother. 2017 Mar 1;72(suppl_1):i39-i47. doi: 10.1093/jac/dkx032.
9
Determining the analytical specificity of PCR-based assays for the diagnosis of IA: What is Aspergillus?确定基于聚合酶链反应(PCR)的检测方法对侵袭性曲霉病(IA)诊断的分析特异性:什么是曲霉菌?
Med Mycol. 2017 Jun 1;55(4):402-413. doi: 10.1093/mmy/myw093.
10
Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.布尔帕标准是否适用于慢性阻塞性肺疾病重症患者可能的侵袭性肺曲霉病的诊断?一项与欧洲癌症研究与治疗组织/侵袭性真菌感染协作组和重症监护病房标准的比较研究。
BMC Infect Dis. 2017 Mar 14;17(1):209. doi: 10.1186/s12879-017-2307-y.